InvestorsHub Logo
Followers 4
Posts 207
Boards Moderated 0
Alias Born 03/06/2022

Re: Hoskuld post# 423329

Tuesday, 07/18/2023 12:31:19 PM

Tuesday, July 18, 2023 12:31:19 PM

Post# of 459924
Indeed, Hoskuld, the efficacy of the placebo is remarkable - so much so that one wonders if the FDA will approve it as well as donanemab - slightly less efficacious, but far lesser concern over side effects. Surely cheaper to produce. If the manufacturer is a publicly traded company perhaps we should go long...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News